Fragrance compositions

Patent metadata

Field	Value
Publication number	US-10072234-B2
Application number	US-201314095477-A
Country	US
Kind code	B2
Filing date	Dec 3, 2013
Priority date	Jul 7, 2003
Publication date	Sep 11, 2018
Grant date	Sep 11, 2018

Abstract

A fragrance composition and use thereof by inhalation to promote activated, pleasant moods. The fragrance composition comprises at least 75% by weight of perfume materials including at least 10% by weight of at least three specific materials from a group identified as Group IMP and optionally up to 90% of specific materials selected from groups identified as HMR, HMI, HMP, RMP and GEN, the amounts of materials from said Groups falling within specified relationships.

First claim

The invention claimed is:

1. A fragrance composition comprising at least 40 perfume ingredients present in an amount of at least 75% by weight, wherein the ingredients are selected from the following groups:
A) at least 15% by weight in total of at least three ingredients are selected from Group ‘IMP’, wherein Group ‘IMP’ comprises: allyl amyl glycolate; benzyl salicylate; bergamot oil; coriander oil; cyclamen aldehyde; 1-(2,6,10-trimethylcyclododeca-2,5,9-trien-1-yl)ethanone; prop-2-enyl (cyclohexyloxy)acetate; Damascenia 185 SAE; 2,4-dimethylheptan-1-ol; fir balsam; fir needle oil; 3-(4-ethylphenyl)-2,2-dimethylpropanal; ginger oil; guaiacwood; linalyl acetate; litsea cubeba oil; methyl 2,4-dihydroxy-3,6-dimethylbenzoate; nutmeg oil; olibanum oil; orange flower oil; Ozonal AB 7203C; patchouli oil; rose oxide; rosemary oil; sage clary oil; spearmint oil; Tamarine AB 8212E; and tarragon oil;
B) optionally up to 90% by weight of the ingredients are selected from the following groups:
Group ‘HMR’ comprising:
allyl ionone; benzyl acetate; cis-jasmone; citronellol; ethyl linalol; ethylene brassylate; 4-methyl-2-(2-methylpropyl)tetrahydro-2H-pyran-4-ol; geraniol; geranium oil; iso-eugenol; lemon oil; 3-(4-hydroxy-4-methylpentyl)cyclohex-3-ene-1-carbaldehyde; 4-(4-hydroxy-4-methylpentyl)cyclohex-3-ene-1-carbaldehyde; alpha-iso-methyl ionone; 3-methylcyclopentadec-2-en-1-one; cyclopentadecanone; cyclohexadecanolide; and gamma-undecalactone;
Group ‘HMI’ comprising:
1-{[2-(1,1-dimethylethyl)cyclohexyl]oxy}butan-2-ol; 3a,6,6,9a-tetramethyldodecahydronaphtho[2,1-{b}]furan; alpha-damascone; dihydromyrcenol; eugenol; 3-(1,3-benzodioxol-5-yl)-2-methylpropanal; 2,4-dimethylcyclohex-3-ene-1-carbaldehyde; mandarin oil; orange oil; and 2-(1,1-dimethylethyl)cyclohexyl acetate;
Group ‘HMP’ comprising:
1-(2,6,6,8-tetramethyltricyclo [5.3.1.0{1,5}]undec-8-en-9-yl)ethanone; allyl cyclohexylpropionate; allyl heptanoate; Apple Oliffac S pcmf; 7-methyl-2H-1, 5-benzodioxepin-3(4H)-one; cassis base; cis-3-hexenyl salicylate; damascenone; gamma-decalactone; ethyl acetoacetate; ethyl maltol; ethyl methyl phenylglycidate; hexyl acetate; (3E)-4-methyldec-3-en-5-ol; 2,5,5-trimethyl-6,6-bis(methyloxy)hex-2-ene; 4-(4-hydroxyphenyl)butan-2-one; styrallyl acetate; 2,2,5-trimethyl-5-pentylcyclopentanone; and ylang oil;
Group ‘RMP’ comprising:
anisic aldehyde; (2Z)-2-ethyl-4-(2,2,3-trimethylcyclopent-3-en-1-yl)but-2-en-1-ol; benzoin siam resinoid; ethyl vanillin; oxacyclohexadec-12(13)-en-2-one; hexyl salicylate; hydroxycitronellal; jasmin oil; 3-methyl-5-phenylpentan-1-ol; 2-(phenyloxy)ethyl 2-methylpropanoate; alpha-terpineol; and vanillin; and
Group ‘GEN’ comprising:
cyclopentadecanolide; hexyl cinnamic aldehyde; ionone beta; isobornyl cyclohexanol; 1-(2,3,8,8-tetramethyl-1,2,3,4,5,6,7(8),8(8a)-octahydronaphthalen-2-yl)ethanone; 3-[4-(1,1-dimethylethyl)phenyl]-2-methylpropanal; linalol; methyl dihydrojasmonate; and 2-phenylethanol;
provided the following conditions (a) through (e) are met:
(a) IMPs >=HMPs +HMRs;
(b) IMPs +HMIs +GENs >=70%;
(c) (IMP +HMI)/(IMP +HMI +RMP +HMR)>=0.7;
(d) IMPs/(HMPs+RMPs+IMPs) >=0.5; and
(e) IMPs/[(HMPs+RMPs+IMPs) +(100-TOTAL)] >=0.3,

wherein ‘IMPs’ indicates the sum of the percentages of the ingredients within Group IMP, and similarly for the remaining groups, the symbol ‘>=’ indicates ‘at least equal to’, and ‘TOTAL’ is the sum of HMPs, HMRs, HMIs, IMPs, RMPs and GENs, provided also that solvents scoring less than 80on an odour index scale based on a comparison with the odour intensity of a control sample of a 10% solution of benzyl acetate in dipropylene glycol, which corresponds to an index of 100 are excluded from the calculation of these sums.

2. A fragrance composition according to claim 1 , where at least 80% by weight of the ingredients are from the total of Groups IMP, HMI and GEN.

3. A fragrance composition according to claim 1 , wherein the ratio of IMPs/(HMPs +RMPs +IMPs) is at least 0.6.

4. A fragrance composition according to claim 1 , where at least five of the ingredients are from Group IMP.

5. A fragrance composition according to claim 4 , where at least eight of the ingredients are from Group IMP.

6. A fragrance composition according to claim 1 , where at least 90% by weight of the ingredients are from the total of Groups IMP, HMI and GEN.

7. A consumer composition comprising a fragrance composition according to claim 1 .

8. A method of providing activated, pleasant moods through inhalation of an effective amount of a fragrance composition according to claim 1 .

9. A process of dispensing a fragrance composition according to claim 1 in an amount and for a time sufficient to provide effective vaporous emission for inhalation by a subject.

10. A fragrance composition according to claim 1 , comprising at least two ingredients from the GEN group.

11. A fragrance composition according to claim 10 , wherein the at least two ingredients are linalol and 3-[4-(1,1-dimethylethyl)phenyl]-2-methylpropanal.

12. A fragrance composition according to claim 1 , comprising at least one ingredient from the HMI group.

13. A fragrance composition according to claim 1 , wherein one of the at least three ingredients present from the IMP group is methyl 2,4-dihydroxy-3,6-dimethylbenzoate.

14. A fragrance composition according to claim 1 , wherein one of the at least three ingredients present from the IMP group is linalyl acetate.

15. A fragrance composition according to claim 1 , comprising at least one ingredient from the RMP group.

16. A fragrance composition according to claim 15 , wherein the at least one ingredient from the RMP group is alpha-terpineol.

17. A fragrance composition according to claim 1 , comprising at least two ingredients from the GEN group and at least one ingredient from the HMI group.

18. A fragrance composition according to claim 17 , further comprising at least one ingredient from the RMP group.

Assignees

• Givaudan Sa

Inventors

• Behan John Martin
• Care Briony
• Churchill Anne
• Evans Michael Gordon
• Perring Keith Douglas
• Provan Alan Forbes

Classifications

• C11B9/02 Primary

  Recovery or refining of essential oils from raw materials · CPC title

• C11B9/00 Primary

  Essential oils; Perfumes · CPC title

• C11B9/008

  the hetero rings containing six atoms · CPC title

• C11B9/0034

  the ring containing six carbon atoms · CPC title

• C11B9/0069

  Heterocyclic compounds · CPC title